Primary Care Hypertension Management: Guidelines From Hypertension Canada

Michael J. Arnold, MD, MHPE

American Family Physician. 2026;114(4):436-438.

Author Disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

KEY POINTS FROM THE GUIDELINE

• The guidelines define hypertension as BP of 130/80 mm Hg or greater using a validated automated device with standardized methods.
• Lifestyle interventions are strongly recommended for all patients with hypertension.
• Medical treatment is recommended when BP is 140/90 mm Hg or greater or systolic BP is 130 mm Hg or greater for patients with established CVD or at high CVD risk due to being 75 years or older or having chronic kidney disease, diabetes, or a 10-year Framingham Risk Score of 20% or greater.
• Treatment should aim to reduce systolic BP to less than 130 mm Hg.
• Low-dose combination therapy is recommended as initial treatment, using a combination of an ACE inhibitor or ARB with a thiazide or thiazide-like diuretic or a long-acting dihydropyridine calcium channel blocker. Add the third drug class if BP control is not achieved. If BP is still not at goal, add spironolactone.

Hypertension is the most common modifiable risk factor for cardiovascular disease (CVD) in Canada, affecting 1 in 4 adults. Hypertension treatment rates have declined in Canada in recent years, possibly due to uncertainty about blood pressure (BP) targets, overly complex guideline recommendations, inadequate implementation strategies, and suboptimal engagement with primary care clinicians. Hypertension Canada published guidelines to provide streamlined, pragmatic, evidence-based recommendations for primary care management of hypertension.

GUIDELINE SUMMARY

BP Assessment

Office. Automated oscillometric BP monitors are recommended over auscultatory sphygmomanometers due to ease of use, reproducibility, and decreased human error. Devices must be validated by the manufacturer.

The measurement procedure should be standardized to increase accuracy:

  • Patient sits with back supported and legs uncrossed, with feet flat on the floor
  • Use appropriately sized cuff for arm
  • Arm should be bare and supported with middle of cuff at heart level and lower edge of cuff about 1 inch (3 cm) above elbow crease
  • 1- to 5-minute rest period before BP measurement
  • Patient should not talk or move from the beginning of the rest period to the final measurement
  • Quiet and calm room
  • No caffeine, tobacco, or exercise 30 minutes before measurements
  • Obtain three measurements at 1-minute intervals; record all three and average

Standardized automated office BP measurements closely approximate daytime ambulatory and home measurements. Manual measurements are often 5 to 10 mm Hg higher.

Out of Office. Out-of-office BP assessment should comprise ambulatory monitoring every 20 to 30 minutes throughout the day and night or home monitoring with two measurements taken twice daily for 1 week. Out-of-office measurements correlate more closely with cardiovascular events and death than office readings. Hypertension Canada strongly recommends out-of-office monitoring to confirm hypertension and reveal masked hypertension. When out-of-office BP measurement is not feasible, hypertension can be confirmed with repeat standardized office measurements.

Hypertension Definition and Treatment Thresholds

The guidelines define hypertension as BP of 130/80 mm Hg or greater. This is based on meta-analysis data that demonstrated a relative risk for major adverse cardiovascular events as 1.5 to 2 times higher than in people with BP less than 120/80 mm Hg. Although risks are higher at 120 to 129 mm Hg systolic and 80 to 84 mm Hg diastolic, this increased risk is substantially less.

MICHAEL J. ARNOLD, MD, MHPE, FAAFP, is the officer in charge at the Naval Undersea Medical Institute, Groton, Connecticut; an associate professor of family medicine at the Uniformed Services University of the Health Sciences F. Edward Hébert School of Medicine, Bethesda, Maryland; and an AFP assistant medical editor.

Address correspondence to Michael J. Arnold, MD, MHPE, at mkcarnold@gmail.com.

Author Disclosure: No relevant financial relationships.

Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.

This series is coordinated by Michael J. Arnold, MD, MHPE, AFP Assistant Medical Editor.

A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.